{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:50:21Z","timestamp":1792176621612,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T00:00:00Z","timestamp":1497916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T00:00:00Z","timestamp":1497916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/tp.2017.123","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T13:40:53Z","timestamp":1497966053000},"page":"e1154-e1154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"7","author":[{"given":"N","family":"Janel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Alexopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Badel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Lamari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A C","family":"Camproux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Lagarde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Feraudet-Tarisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Lamourette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Arbones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J L","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M C","family":"Potier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Sarazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Delabar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,20]]},"reference":[{"key":"BFtp2017123_CR1","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","volume":"377","author":"C Ballard","year":"2011","unstructured":"Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E . Alzheimer's disease. Lancet 2011; 377: 1019\u20131031.","journal-title":"Lancet"},{"key":"BFtp2017123_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.neuron.2011.01.002","volume":"69","author":"TE Golde","year":"2011","unstructured":"Golde TE, Schneider LS, Koo EH . Anti-abeta therapeutics in Alzheimer's disease: the need for a paradigm shift. Neuron 2011; 69: 203\u2013213.","journal-title":"Neuron"},{"key":"BFtp2017123_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.nbd.2014.04.016","volume":"69","author":"B Souchet","year":"2014","unstructured":"Souchet B, Guedj F, Sahun I, Duchon A, Daubigney F, Badel A et al. Excitation\/inhibition balance and learning are modified by Dyrk1a gene dosage. Neurobiol Dis 2014; 69: 65\u201375.","journal-title":"Neurobiol Dis"},{"key":"BFtp2017123_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.bbrc.2008.11.126","volume":"378","author":"J Hamelet","year":"2009","unstructured":"Hamelet J, Noll C, Ripoll C, Paul JL, Janel N, Delabar JM . Effect of hyperhomocysteinemia on the protein kinase DYRK1A in liver of mice. Biochem Biophys Res Commun 2009; 378: 673\u2013677.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFtp2017123_CR5","doi-asserted-by":"publisher","first-page":"05920","DOI":"10.7554\/eLife.05920","volume":"4","author":"B Khor","year":"2015","unstructured":"Khor B, Gagnon JD, Goel G, Roche MI, Conway KL, Tran K et al. The kinase DYRK1A reciprocally regulates the differentiation of Th17 and regulatory T cells. Elife 2015; 4: 05920.","journal-title":"Elife"},{"key":"BFtp2017123_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/hmg\/ddl437","volume":"16","author":"R Kimura","year":"2007","unstructured":"Kimura R, Kamino K, Yamamoto M, Nuripa A, Kida T, Kazui H et al. The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease. Hum Mol Genet 2007; 16: 15\u201323.","journal-title":"Hum Mol Genet"},{"key":"BFtp2017123_CR7","doi-asserted-by":"publisher","first-page":"e4606","DOI":"10.1371\/journal.pone.0004606","volume":"4","author":"F Guedj","year":"2009","unstructured":"Guedj F, Sebrie C, Rivals I, Ledru A, Paly E, Bizot JC et al. Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A. PLoS ONE 2009; 4: e4606.","journal-title":"PLoS ONE"},{"key":"BFtp2017123_CR8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.nbd.2010.06.011","volume":"40","author":"D Toiber","year":"2010","unstructured":"Toiber D, Azkona G, Ben-Ari S, Toran N, Soreq H, Dierssen M . Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations. Neurobiol Dis 2010; 40: 348\u2013359.","journal-title":"Neurobiol Dis"},{"key":"BFtp2017123_CR9","doi-asserted-by":"publisher","first-page":"e7540","DOI":"10.1371\/journal.pone.0007540","volume":"4","author":"C Noll","year":"2009","unstructured":"Noll C, Planque C, Ripoll C, Guedj F, Diez A, Ducros V et al. DYRK1A, a novel determinant of the methionine-homocysteine cycle in different mouse models overexpressing this Down-syndrome-associated kinase. PLoS ONE 2009; 4: e7540.","journal-title":"PLoS ONE"},{"key":"BFtp2017123_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12031-012-9835-0","volume":"50","author":"C Planque","year":"2013","unstructured":"Planque C, Dairou J, Noll C, Bui LC, Ripoll C, Guedj F et al. Mice deficient in cystathionine beta synthase display increased Dyrk1A and SAHH activities in brain. J Mol Neurosci 2013; 50: 1\u20136.","journal-title":"J Mol Neurosci"},{"key":"BFtp2017123_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12035-012-8326-1","volume":"47","author":"S Abekhoukh","year":"2013","unstructured":"Abekhoukh S, Planque C, Ripoll C, Urbaniak P, Paul JL, Delabar JM et al. Dyrk1A, a serine\/threonine kinase, is involved in ERK and Akt activation in the brain of hyperhomocysteinemic mice. Mol Neurobiol 2013; 47: 105\u2013116.","journal-title":"Mol Neurobiol"},{"key":"BFtp2017123_CR12","doi-asserted-by":"publisher","first-page":"e425","DOI":"10.1038\/tp.2014.61","volume":"4","author":"N Janel","year":"2014","unstructured":"Janel N, Sarazin M, Corlier F, Corne H, de Souza LC, Hamelin L et al. Plasma DYRK1A as a novel risk factor for Alzheimer's disease. Transl Psychiatry 2014; 4: e425.","journal-title":"Transl Psychiatry"},{"key":"BFtp2017123_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s12035-012-8284-7","volume":"46","author":"A Tlili","year":"2012","unstructured":"Tlili A, Hoischen A, Ripoll C, Benabou E, Badel A, Ronan A et al. BDNF and DYRK1A are variable and inversely correlated in lymphoblastoid cell lines from Down syndrome patients. Mol Neurobiol 2012; 46: 297\u2013303.","journal-title":"Mol Neurobiol"},{"key":"BFtp2017123_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.pnpbp.2013.12.001","volume":"50","author":"J Platenik","year":"2014","unstructured":"Platenik J, Fisar Z, Buchal R, Jirak R, Kitzlerova E, Zverova M et al. GSK3beta, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression. Prog Neuropsychopharmacol Biol Psychiatry 2014; 50: 83\u201393.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFtp2017123_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jalz.2010.08.234","volume":"7","author":"DS Wald","year":"2011","unstructured":"Wald DS, Kasturiratne A, Simmonds M . Serum homocysteine and dementia: meta-analysis of eight cohort studies including 8669 participants. Alzheimers Dement 2011; 7: 412\u2013417.","journal-title":"Alzheimers Dement"},{"key":"BFtp2017123_CR16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 280\u2013292.","journal-title":"Alzheimers Dement"},{"key":"BFtp2017123_CR17","first-page":"82","volume":"10","author":"T Grimmer","year":"2013","unstructured":"Grimmer T, Wutz C, Drzezga A, Forster S, Forstl H, Ortner M et al. The usefulness of amyloid imaging in predicting the clinical outcome after two years in subjects with mild cognitive impairment. Curr Alzheimer Res 2013; 10: 82\u201385.","journal-title":"Curr Alzheimer Res"},{"key":"BFtp2017123_CR18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 270\u2013279.","journal-title":"Alzheimers Dement"},{"key":"BFtp2017123_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 263\u2013269.","journal-title":"Alzheimers Dement"},{"key":"BFtp2017123_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00401-012-1041-1","volume":"125","author":"AN Lazar","year":"2013","unstructured":"Lazar AN, Bich C, Panchal M, Desbenoit N, Petit VW, Touboul D et al. Time-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging reveals cholesterol overload in the cerebral cortex of Alzheimer disease patients. Acta Neuropathol 2013; 125: 133\u2013144.","journal-title":"Acta Neuropathol"},{"key":"BFtp2017123_CR21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.nbd.2012.01.007","volume":"46","author":"F Guedj","year":"2012","unstructured":"Guedj F, Pereira PL, Najas S, Barallobre MJ, Chabert C, Souchet B et al. DYRK1A: a master regulatory protein controlling brain growth. Neurobiol Dis 2012; 46: 190\u2013203.","journal-title":"Neurobiol Dis"},{"key":"BFtp2017123_CR22","doi-asserted-by":"publisher","first-page":"6636","DOI":"10.1128\/MCB.22.18.6636-6647.2002","volume":"22","author":"V Fotaki","year":"2002","unstructured":"Fotaki V, Dierssen M, Alcantara S, Martinez S, Marti E, Casas C et al. Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice. Mol Cell Biol 2002; 22: 6636\u20136647.","journal-title":"Mol Cell Biol"},{"key":"BFtp2017123_CR23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ab.2013.12.024","volume":"449","author":"LC Bui","year":"2014","unstructured":"Bui LC, Tabouy L, Busi F, Dupret JM, Janel N, Planque C et al. A high-performance liquid chromatography assay for Dyrk1a, a Down syndrome-associated kinase. Anal Biochem 2014; 449: 172\u2013178.","journal-title":"Anal Biochem"},{"key":"BFtp2017123_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0022-1759(87)90180-3","volume":"100","author":"LM Reik","year":"1987","unstructured":"Reik LM, Maines SL, Ryan DE, Levin W, Bandiera S, Thomas PE . A simple, non-chromatographic purification procedure for monoclonal antibodies. Isolation of monoclonal antibodies against cytochrome P450 isozymes. J Immunol Methods 1987; 100: 123\u2013130.","journal-title":"J Immunol Methods"},{"key":"BFtp2017123_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM . A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88\u201395.","journal-title":"Biochem Pharmacol"},{"key":"BFtp2017123_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0022-1759(89)90223-8","volume":"123","author":"J Grassi","year":"1989","unstructured":"Grassi J, Frobert Y, Pradelles P, Chercuitte F, Gruaz D, Dayer JM et al. Production of monoclonal antibodies against interleukin-1 alpha and -1 beta. Development of two enzyme immunometric assays (EIA) using acetylcholinesterase and their application to biological media. J Immunol Methods 1989; 123: 193\u2013210.","journal-title":"J Immunol Methods"},{"key":"BFtp2017123_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0022-1759(94)90335-2","volume":"175","author":"H Volland","year":"1994","unstructured":"Volland H, Vulliez Le Normand B, Mamas S, Grassi J, Creminon C, Ezan E et al. Enzyme immunometric assay for leukotriene C4. J Immunol Methods 1994; 175: 97\u2013105.","journal-title":"J Immunol Methods"},{"key":"BFtp2017123_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1570-0232(02)00497-X","volume":"781","author":"V Ducros","year":"2002","unstructured":"Ducros V, Demuth K, Sauvant MP, Quillard M, Causse E, Candito M et al. Methods for homocysteine analysis and biological relevance of the results. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 781: 207\u2013226.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"BFtp2017123_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fnagi.2016.00273","volume":"8","author":"E Neto","year":"2016","unstructured":"Neto E, Biessmann F, Aurlien H, Nordby H, Eichele T . Regularized linear discriminant analysis of EEG features in dementia patients. Front Aging Neurosci 2016; 8: 273.","journal-title":"Front Aging Neurosci"},{"key":"BFtp2017123_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-nutr-071715-050947","volume":"36","author":"AD Smith","year":"2016","unstructured":"Smith AD, Refsum H . Homocysteine, B vitamins, and cognitive impairment. Annu Rev Nutr 2016; 36: 211\u2013239.","journal-title":"Annu Rev Nutr"},{"key":"BFtp2017123_CR31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.neuron.2016.03.027","volume":"90","author":"KM Ori-McKenney","year":"2016","unstructured":"Ori-McKenney KM, McKenney RJ, Huang HH, Li T, Meltzer S, Jan LY et al. Phosphorylation of beta-tubulin by the Down syndrome kinase, minibrain\/DYRK1a, regulates microtubule dynamics and dendrite morphogenesis. Neuron 2016; 90: 551\u2013563.","journal-title":"Neuron"},{"key":"BFtp2017123_CR32","doi-asserted-by":"publisher","first-page":"3648","DOI":"10.1523\/JNEUROSCI.2517-15.2016","volume":"36","author":"M Ruiz-Mejias","year":"2016","unstructured":"Ruiz-Mejias M, Martinez de Lagran M, Mattia M, Castano-Prat P, Perez-Mendez L, Ciria-Suarez L et al. Overexpression of Dyrk1A, a Down syndrome candidate, decreases excitability and impairs gamma oscillations in the prefrontal cortex. J Neurosci 2016; 36: 3648\u20133659.","journal-title":"J Neurosci"},{"key":"BFtp2017123_CR33","doi-asserted-by":"publisher","first-page":"33343","DOI":"10.1074\/jbc.M109.042234","volume":"284","author":"Y Lee","year":"2009","unstructured":"Lee Y, Ha J, Kim HJ, Kim YS, Chang EJ, Song WJ et al. Negative feedback Inhibition of NFATc1 by DYRK1A regulates bone homeostasis. J Biol Chem 2009; 284: 33343\u201333351.","journal-title":"J Biol Chem"},{"key":"BFtp2017123_CR34","doi-asserted-by":"publisher","first-page":"15219","DOI":"10.1074\/jbc.M115.645507","volume":"290","author":"N Jin","year":"2015","unstructured":"Jin N, Yin X, Gu J, Zhang X, Shi J, Qian W et al. Truncation and activation of dual specificity tyrosine phosphorylation-regulated kinase 1A by Calpain I: a molecular mechanism linked to tau pathology in Alzheimer disease. J Biol Chem 2015; 290: 15219\u201315237.","journal-title":"J Biol Chem"},{"key":"BFtp2017123_CR35","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nm.4050","volume":"22","author":"RS Duman","year":"2016","unstructured":"Duman RS, Aghajanian GK, Sanacora G, Krystal JH . Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med 2016; 22: 238\u2013249.","journal-title":"Nat Med"},{"key":"BFtp2017123_CR36","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1124\/pr.111.005108","volume":"64","author":"AE Autry","year":"2012","unstructured":"Autry AE, Monteggia LM . Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 2012; 64: 238\u2013258.","journal-title":"Pharmacol Rev"},{"key":"BFtp2017123_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/brb3.23","volume":"1","author":"A Carrard","year":"2011","unstructured":"Carrard A, Salzmann A, Perroud N, Gafner J, Malafosse A, Karege F . Genetic association of the Phosphoinositide-3 kinase in schizophrenia and bipolar disorder and interaction with a BDNF gene polymorphism. Brain Behav 2011; 1: 119\u2013124.","journal-title":"Brain Behav"},{"key":"BFtp2017123_CR38","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1016\/j.pnpbp.2011.09.004","volume":"35","author":"T Niitsu","year":"2011","unstructured":"Niitsu T, Shirayama Y, Matsuzawa D, Hasegawa T, Kanahara N, Hashimoto T et al. Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 1836\u20131840.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFtp2017123_CR39","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.psychres.2012.04.026","volume":"199","author":"HW Koenigsberg","year":"2012","unstructured":"Koenigsberg HW, Yuan P, Diaz GA, Guerreri S, Dorantes C, Mayson S et al. Platelet protein kinase C and brain-derived neurotrophic factor levels in borderline personality disorder patients. Psychiatry Res 2012; 199: 92\u201397.","journal-title":"Psychiatry Res"},{"key":"BFtp2017123_CR40","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/0896-6273(91)90273-3","volume":"7","author":"HS Phillips","year":"1991","unstructured":"Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, Winslow JW . BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 1991; 7: 695\u2013702.","journal-title":"Neuron"},{"key":"BFtp2017123_CR41","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/00005072-199907000-00007","volume":"58","author":"I Ferrer","year":"1999","unstructured":"Ferrer I, Marin C, Rey MJ, Ribalta T, Goutan E, Blanco R et al. BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J Neuropathol Exp Neurol 1999; 58: 729\u2013739.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFtp2017123_CR42","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.nlm.2007.08.018","volume":"89","author":"Y Lu","year":"2008","unstructured":"Lu Y, Christian K, Lu B . BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory? Neurobiol Learn Mem 2008; 89: 312\u2013323.","journal-title":"Neurobiol Learn Mem"},{"key":"BFtp2017123_CR43","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12017-011-8154-x","volume":"13","author":"BS Diniz","year":"2011","unstructured":"Diniz BS, Teixeira AL . Brain-derived neurotrophic factor and Alzheimer's disease: physiopathology and beyond. Neuromol Med 2011; 13: 217\u2013222.","journal-title":"Neuromol Med"},{"key":"BFtp2017123_CR44","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.nlm.2008.07.014","volume":"90","author":"P Komulainen","year":"2008","unstructured":"Komulainen P, Pedersen M, Hanninen T, Bruunsgaard H, Lakka TA, Kivipelto M et al. BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study. Neurobiol Learn Mem 2008; 90: 596\u2013603.","journal-title":"Neurobiol Learn Mem"},{"key":"BFtp2017123_CR45","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3109\/15622971003797241","volume":"11","author":"OV Forlenza","year":"2010","unstructured":"Forlenza OV, Diniz BS, Teixeira AL, Ojopi EB, Talib LL, Mendonca VA et al. Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. World J Biol Psychiatry 2010; 11: 774\u2013780.","journal-title":"World J Biol Psychiatry"},{"key":"BFtp2017123_CR46","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1016\/j.bbamcr.2016.09.018","volume":"1863","author":"LG Rabaneda","year":"2016","unstructured":"Rabaneda LG, Geribaldi-Doldan N, Murillo-Carretero M, Carrasco M, Martinez-Salas JM, Verastegui C et al. Altered regulation of the Spry2\/Dyrk1A\/PP2A triad by homocysteine impairs neural progenitor cell proliferation. Biochim Biophys Acta 2016; 1863: 3015\u20133026.","journal-title":"Biochim Biophys Acta"},{"key":"BFtp2017123_CR47","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMoa011613","volume":"346","author":"S Seshadri","year":"2002","unstructured":"Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346: 476\u2013483.","journal-title":"N Engl J Med"},{"key":"BFtp2017123_CR48","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.neurobiolaging.2009.02.024","volume":"32","author":"DE Zylberstein","year":"2011","unstructured":"Zylberstein DE, Lissner L, Bjorkelund C, Mehlig K, Thelle DS, Gustafson D et al. Midlife homocysteine and late-life dementia in women. A prospective population study. Neurobiol Aging 2011; 32: 380\u2013386.","journal-title":"Neurobiol Aging"},{"key":"BFtp2017123_CR49","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ymgme.2009.02.005","volume":"97","author":"J Hamelet","year":"2009","unstructured":"Hamelet J, Couty JP, Crain AM, Noll C, Postic C, Paul JL et al. Calpain activation is required for homocysteine-mediated hepatic degradation of inhibitor I kappa B alpha. Mol Genet Metab 2009; 97: 114\u2013120.","journal-title":"Mol Genet Metab"},{"key":"BFtp2017123_CR50","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1007\/s00726-016-2280-6","volume":"48","author":"Y Jang","year":"2016","unstructured":"Jang Y, Kim J, Ko JW, Kwon YH . Homocysteine induces PUMA-mediated mitochondrial apoptosis in SH-SY5Y cells. Amino Acids 2016; 48: 2559\u20132569.","journal-title":"Amino Acids"},{"key":"BFtp2017123_CR51","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/embor.2011.98","volume":"12","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Liao JM, Zeng SX, Lu H . p53 downregulates Down syndrome-associated DYRK1A through miR-1246. EMBO Rep 2011; 12: 811\u2013817.","journal-title":"EMBO Rep"},{"key":"BFtp2017123_CR52","doi-asserted-by":"publisher","first-page":"10755","DOI":"10.1074\/jbc.M110.174540","volume":"286","author":"M Lu","year":"2011","unstructured":"Lu M, Zheng L, Han B, Wang L, Wang P, Liu H et al. REST regulates DYRK1A transcription in a negative feedback loop. J Biol Chem 2011; 286: 10755\u201310763.","journal-title":"J Biol Chem"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tp2017123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp2017123","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/tp.2017.123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/tp2017123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T16:58:26Z","timestamp":1671728306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp2017123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,20]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6]]}},"alternative-id":["BFtp2017123"],"URL":"https:\/\/doi.org\/10.1038\/tp.2017.123","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,20]]},"assertion":[{"value":"23 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}